Ying He

Ying He

Auto-generated profile, based on publicly available information

Ying He

Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Nanfang Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2010 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
LTLuxia Tu
Luxia Tu
ZLZhen Liu
Zhen Liu
XHXiufang He
Xiufang He
YHYing He
Ying He
HYHuiling Yang
Huiling Yang
WFWeiyi Fang
Weiyi Fang
Background: The aim of the present study was to analyze the expression of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in nasopharyngeal carcinoma (NPC) and its correlation with clinicopathologic features, including patients' survival time. Methods: Using real-time PCR, we detected the expression of EIF4G1 in normal nasopharyngeal tissues, immortalized nasopharyngeal epithelial cell lines NP69, NPC tissues and cell lines. EIF4G1 protein expression in NPC tissues was examined using immunohistochemistry. Survival analysis was performed using Kaplan-Meier method. The effect of EIF4G1 on cell invasion and tumorigenesis were investigated. Results: The expression levels of EIF4G1 mRNA were significantly greater in NPC tissues and cell lines than those in the normal nasopharyngeal tissues and NP69 cells (P < 0.001). Immunohistochemical analysis revealed that the expression of EIF4G1 protein was higher in NPC tissues than that in the nasopharyngeal tissues (P < 0.001). In addition, the levels of EIF4G1 protein in tumors were positively correlated with tumor T classification (P = 0.039), lymph node involvement (N classification, P = 0.008), and the clinical stages (P = 0.003) of NPC patients. Patients with higher EIF4G 1 expression had shorter overall survival time (P = 0.019). Multivariate analysis showed that EIF4G1 expression was an independent prognostic indicator for the overall survival of NPC patients. Using shRNA to knock down the expression of EIF4G1 not only markedly inhibited cell cycle progression, proliferation, migration, invasion, and colony formation, but also dramatically suppressed in vivo xenograft tumor growth. Conclusion: Our data suggest that EIF4G1 can serve as a biomarker for the prognosis of NPC patients.

1 January 2009
Verified
Journal Article
Closed access
YHYing He
Ying He
GZGang-Qiao Zhou
Gang-Qiao Zhou
XLXin Li
Xin Li
XDXiao-Jia Dong
Xiao-Jia Dong
KYKai-Tai Yao
Kai-Tai Yao

19 June 2020 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
BLBeina Liu
Beina Liu
RWRong Wang
Rong Wang
YHYing He
Ying He

1 March 2008
Verified
Journal Article
Closed access
YHYing He
Ying He
LLLin Lin
Lin Lin
XLXiao-Long Liu
Xiao-Long Liu